Biotech Values

[Shengli]

"In some instances, a particularly aggressive form of recurrent HCV develops within only a few months post-LTx and this condition has been labelled “fibrosing cholestatic hepatitis” (FCH) "


of course this is not as common but reinfection occurs rapidly and almost at a 100% rate . We know the problem with Interferon and Riba in this compromised group. An all oral regimen would have to show very low SVR rates to get an approval.I think its a brilliant idea considering we have quickly outstripped our liver supply and are tilted toward an epidemic in a few years. LT doctors are desperate.